Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Issue : February 2005

View all stories from this issue.

Sort By: Newest firstOldest firstA-ZZ-A

  • ChlorphenamineSubscription

    Clinical25 February, 2005

    VOL: 101, ISSUE: 32, PAGE NO: 31Generic and proprietary names

  • Developing a chest pain team to fast track AMI patients.Subscription

    Clinical22 February, 2005

    VOL: 101, ISSUE: 08, PAGE NO: 34Phil Hill, BSc, RN, Dip Management, is emergency unit practitioner, medical emergency admissions unit, Llandough Hospital, Penarth.Although the UK death rate from coronary heart disease (CHD) is falling, 270,000 AMIs occur each year and CHD is the most common cause of death in the UK (Webb et al, 1999; NAW, 2002). In some parts of Wales, the death rate from AMIs is the highest in western Europe.

  • Provision of safe drinking water immunocompromised patients.Subscription

    Clinical22 February, 2005

    VOL: 101, ISSUE: 08, PAGE NO: 51Immunocompromised patients are at risk from pathogenic microorganisms in drinking water. However, until recently there has been a lack of concise guidelines on the provision of safe drinking water for such patients.

  • Managing acute and chronic pain in sickle cell disease.Subscription

    Clinical22 February, 2005

    Sickle cell disease (SCD) encompasses a group of haemoglobinopathies. There is currently no cure for adults with this hereditary disease, which mainly affects people of Afro-Caribbean origin and, to a lesser extent, Mediterranean, Middle Eastern and Asian groups. There are large numbers of people around the world who suffer from acute or chronic pain, or indeed both, as a result of SCD. Their quality of life is largely determined by the severity of their symptoms and the standard of ...

  • The effectiveness of the national cleanyourhands campaign.Subscription

    Clinical22 February, 2005

    VOL: 101, ISSUE: 08, PAGE NO: 50Julie Storr, RGN, RHV, BN, MBA, FRSA, Cert(Infection control), is safer practice lead, National Patient Safety AgencyThe cleanyourhands campaign currently being rolled out across England and Wales is the first of its kind and is an ambitious attempt to improve hand hygiene on a national level. Nurses are vital to this effort as they are well placed to ensure that hand hygiene compliance is observed.

  • Raising awareness of Raynaud's phenomenon and scleroderma.Subscription

    Clinical22 February, 2005

    VOL: 101, ISSUE: 08, PAGE NO: 30 Anne H. Mawdsley, MBE, is chief executive, Raynaud’s and Scleroderma Association, Alsager, Cheshire Susan J. Brown, MSc, RGN, EN(G), is clinical nurse specialist in connective tissue diseases, Royal National Hospital for Rheumatic Diseases NHS Trust, Bath, Somerset.

  • The special needs of children receiving intravenous therapy.Subscription

    Clinical22 February, 2005

    VOL: 101, ISSUE: 08, PAGE NO: 59Susan MacQueen, MSc, RGN, RSCN, is clinical nurse specialist and lead clinician in infection control, Department of Microbiology, Great Ormond Street Hospital for Children, LondonSusan MacQueen, MSc, RGN, RSCN, is clinical nurse specialist and lead clinician in infection control, Department of Microbiology, Great Ormond Street Hospital for Children, London

  • Best practice in urinary catheterisation and catheter care.Subscription

    Clinical22 February, 2005

    VOL: 101, ISSUE: 08, PAGE NO: 54 Penny Bond, MSc, RN, is professional practice development officer, NHS Quality Improvement Scotland Chris Harris, RN, is urology nurse specialist, Western General Hospital, Edinburgh

  • Wound infection.Subscription

    Clinical22 February, 2005

    VOL: 101, ISSUE: 08, PAGE NO: 32

  • Minimising cross-infection risks associated with beds and mattresses.Subscription

    Clinical22 February, 2005

    VOL: 101, ISSUE: 08, PAGE NO: 52Shila Patel, RGN, BSc, Dip(Infection control), is clinical nurse specialist, infection control, Epsom and St. Helier University Hospitals NHS TrustBed frames and mattresses as a source of risk

Show  10 per page20 per page50 per page